Effect of mammalian target of rapamycin inhibitors on cytomegalovirus infection in kidney transplant recipients receiving polyclonal antilymphocyte globulins: a propensity score-matching analysis-Reference-Cited by-同舟云学术

Effect of mammalian target of rapamycin inhibitors on cytomegalovirus infection in kidney transplant recipients receiving polyclonal antilymphocyte globulins: a propensity score-matching analysis

Published:2016-09-26 Issue:11 Volume:29 Page:1216-1225
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

Cervera Carlos¹²,Cofan Frederic³,Hernandez Cristina¹,Soy Dolors⁴,Marcos Maria Angeles⁵,Sanclemente Gemma¹,Bodro Marta¹,Moreno Asunción¹,Diekmann Fritz³,Campistol Josep Maria³,Oppenheimer Frederic³

Affiliation:

1. Division of Infectious Diseases; Department of Medicine; University of Alberta; Edmonton AB Canada

2. Division of Infectious Diseases; IDIBAPS; Hospital Clinic of Barcelona; University of Barcelona; Barcelona Spain

3. Renal Transplantation Unit; Division of Nephrology; IDIBAPS; Hospital Clinic of Barcelona; University of Barcelona; Barcelona Spain

4. Division of Pharmacy; IDIBAPS; Hospital Clinic of Barcelona; University of Barcelona; Barcelona Spain

5. Division of Microbiology; Centre Diagnòstic Biomèdic (CDB); Centre for International Health Research (CRESIB); IDIBAPS; Hospital Clinic of Barcelona; University of Barcelona; Barcelona Spain

Publisher

Frontiers Media SA

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tri.12848/fullpdf

Reference34 articles.

1. CMV: prevention, diagnosis and therapy;Kotton;Am J Transplant,2013

2. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation;Kotton;Transplantation,2013

3. Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients;Owers;Cochrane Database Syst Rev,2013

4. GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients;De la Torre-Cisneros;Enferm Infecc Microbiol Clin,2011

5. Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms;Brennan;Rev Med Virol,2013

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. QuantiFERON-CMV as a Predictor of CMV Events During Preemptive Therapy in CMV-seropositive Kidney Transplant Recipients;Transplantation;2023-11-22

2. Two Cases of Kidney Transplant Recipients With Multiple Relapsing Pure Red Cell Aplasia Due to Parvovirus B19 Infection;Experimental and Clinical Transplantation;2022-10-18

3. Real-World Treatment Patterns of Antiviral Prophylaxis for Cytomegalovirus Among Adult Kidney Transplant Recipients: A Linked USRDS-Medicare Database Study;Transplant International;2022-08-12

4. Polygenic Innate Immunity Score to Predict the Risk of Cytomegalovirus Infection in CMV D+/R- Transplant Recipients. A Prospective Multicenter Cohort Study;Frontiers in Immunology;2022-08-09

5. Viral‐specific cytotoxic T‐cell responses in HLA‐sensitized kidney transplant patients maintained on everolimus and low‐dose tacrolimus;Transplant Infectious Disease;2022-03-03